Description:
James Lee received his B.S and M.S. in Structural Biology from Seoul National University, he held various roles in research, research planning, and business development at LG Chem. In year 2000, James co-founded Crystal Genomics where he led fundraising and business development activities. In 2008, he founded Rexbio, an early-stage biotech startup specialized in discovering and developing therapeutics and diagnostics for the treatment of pancreatic cancer.

James founded Bridge Biotherapeutics Inc. in 2015 and he currently serves as the CEO. Bridge has been recognized with the continuous advancement of clinical-stage programs focused on pulmonary fibrosis, lung cancer, and immunology. In 2019, James successfully orchestrated the licensing-out deal with Boehringer Ingelheim, which marked as one of the largest global deals on a single compound in Korea.

Host: Serghei Glinca

Contact to James Lee: [ Ссылка ]

Listen on:
Apple Podcast: [ Ссылка ]
Google Podcast: [ Ссылка ]
Spotify: [ Ссылка ]
Amazon Music: [ Ссылка ]

Follow us on social media: [ Ссылка ]

Visit our website: [ Ссылка ]

Thanks CSL Behring for supporting this episode.

#biotech #innovation #inspiration #entrepreneur #therapeutics #foundersinbiotech

свернуть